---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-23-000012"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2023-02-28T23:59:59+00:00"
generated_at: "2026-06-18T22:30:35.193372+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Clover Health Q4 revenue $898.8M; Insurance MCR improves to 92.4% from 102.8% YoY

## Summary
- Full year 2022 Insurance MCR improved to 91.8% from 106.0% in 2021, a 1,420 bps improvement.
- Q4 net loss narrowed to $84.0M from $187.2M; Adjusted EBITDA loss improved to $81.1M from $87.4M.
- 2023 guidance: Insurance MCR 89%-91%, Non-Insurance MCR 98%-100%.
- Consolidated cash and investments $555.3M; parent-level liquidity $331.7M expected to cover 2023 needs.
- Non-Insurance MCR remained above 100% at 103.6% in Q4 and 103.4% for full year.

## SEC filing metadata
- accession: 0001801170-23-000012
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2023-02-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000012/0001801170-23-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000012/clov-20230228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-23-000012
- JSON: https://secwatch.observer/filing/0001801170-23-000012.json
- Plain text: https://secwatch.observer/filing/0001801170-23-000012.txt

## Key facts
- Earnings Releases
  CLOVER HEALTH INVESTMENTS, CORP. /DE reported the fiscal year ended December 31, 2022 results: revenue $ 3,476.7, net income (338.8). Guidance initiated.
  - Period: the fiscal year ended December 31, 2022
  - Revenue: $ 3,476.7
  - Net income: (338.8)
  - Guidance: initiated
  - Result: reported results
  source text: Total revenue $ 898.8 $ 432.0 $ 3,476.7 $ 1,472.0 Insurance MCR 92.4 % 102.8 % 91.8 % 106.0 % Non-Insurance MCR 103.6 103.0 103.4 105.7 Salaries and benefits plus General and administrative expenses ("SG&A") (1) $ 124.3 $ 114.1 $ 486.6 $ 445.7 Adjusted Salaries and benefits plus General and administrative expenses ("Adjusted SG&A") (non-GAAP) (1)(2)(3) 85.6 77.5 320.7 264.4 Net loss (84.0) (187.2) (338.8) (587.8)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000012/0001801170-23-000012-index.htm
- Earnings Releases
  CLOVER HEALTH INVESTMENTS, CORP. /DE reported the fourth quarter ended December 31, 2022 results: revenue $ 898.8, net income (84.0). Guidance initiated.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $ 898.8
  - Net income: (84.0)
  - Guidance: initiated
  - Result: reported results
  source text: Total revenue $ 898.8 $ 432.0 $ 3,476.7 $ 1,472.0 Insurance MCR 92.4 % 102.8 % 91.8 % 106.0 % Non-Insurance MCR 103.6 103.0 103.4 105.7 Salaries and benefits plus General and administrative expenses ("SG&A") (1) $ 124.3 $ 114.1 $ 486.6 $ 445.7 Adjusted Salaries and benefits plus General and administrative expenses ("Adjusted SG&A") (non-GAAP) (1)(2)(3) 85.6 77.5 320.7 264.4 Net loss (84.0) (187.2) (338.8) (587.8)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000012/0001801170-23-000012-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.